Tersolisib is a potent phosphatidylinositol 3-kinase (PI3K) inhibitor within the AKT/mTOR pathway modulator class, primarily researched for its therapeutic potential in treating advanced colorectal cancer… Read more
Tersolisib is a potent phosphatidylinositol 3-kinase (PI3K) inhibitor within the AKT/mTOR pathway modulator class, primarily researched for its therapeutic potential in treating advanced colorectal cancer and various solid tumors. By effectively blocking the PI3K/AKT/mTOR signaling cascade, this compound serves to inhibit abnormal cell proliferation and induce apoptosis in resistant cancer cells. Pharmaceutical laboratories rely on a comprehensive range of Tersolisib related compounds, including synthetic impurities, metabolic products, and stable isotope labelled standards, to facilitate rigorous analytical testing. These reference materials are critical for impurity profiling, method validation, and ensuring accurate quality control during drug development. Utilizing these high-quality standards enables precise identification and quantification of degradation products or drug metabolites, ensuring compliance with strict regulatory requirements for drug safety and consistency in pharmaceutical analysis.